Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Acetaminophen

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

100%

2 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Phase 3 (1)
Phase 4 (1)

Trial Status

Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Research Network

Common Treatments

  • Acetaminophen1
  • Methylnaltrexone Moa7281

Active Sponsors

  • Centre hospitalier de l'Université de Montréal (CHUM)1
  • Bausch Health Americas, Inc.1

Top Investigators

Related Conditions

  • Epidural Analgesia1
  • Opioid Consumption Postoperative1
  • Length Of Stay1
  • Mobility1
  • Post Operative Analgesia1

Activity Timeline